Add like
Add dislike
Add to saved papers

Lipidic Mesophase-embedded Palladium Nanoparticles: Synthesis and Tunable Catalysts in Suzuki-Miyaura Cross Coupling Reactions.

Lipidic cubic phases (LCPs) can reduce Pd2+-salts to palladium nanoparticles (PdNPs) of ~ 5 nm size in their confined water channels under mild conditions. The resulting PdNP-containing LCPs were used as nanoreactor scaffolds to catalyze Suzuki-Miyaura cross coupling reactions in the aqueous channels of the mesophase. To turn on catalysis, PdNP-containing LCPs are activated by swelling the aqueous channels of the lipidic framework, thereby enabling diffusion of the water-soluble substrates to the catalysts. The mesophases play a threefold role: they act as the reducing agent for Pd2+, as a limiting template for their growth, and as a support. The system was characterized and investigated by small-angle X-ray scattering (SAXS), cryo-transmission electron microscopy (cryo-TEM), dynamic light scattering (DLS) and nuclear magnetic resonance (NMR). Bulk LCPs as well as three dispersed palladium/lipid hybrid nanoparticle types were applied in catalysis. The latter - liposomes, hexosomes and cubosomes - can be obtained by design through combination of lipid and additive. The Suzuki-Miyaura cross coupling of 5-iodo-2'-deoxyuridine and phenylboronic acid was used as a model reaction to study these systems. Bulk Pd-LCPs deliver the Suzuki-Miyaura product in 24 h in conversions up to 98 % at room temperature, whereas with palladium/lipid dispersions at 40 °C 68 % of the starting material was transformed to the product after 72 h.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app